» Articles » PMID: 27118621

Multicenter Cohort Study of Acute Myocardial Infarction in Korea - Interim Analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry

Overview
Journal Circ J
Date 2016 Apr 28
PMID 27118621
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Korea Acute Myocardial Infarction Registry (KAMIR)-National Institutes of Health (NIH) registry has the aim of evaluating the clinical characteristics, management, and long-term outcomes of patients with acute myocardial infarction (AMI) in Korea.

Methods and results: Patients hospitalized for AMI in 20 tertiary university hospitals in Korea have been enrolled since November 2011. The study is expected to complete the scheduled enrollment of approximately 13,000 patients in October 2015, and follow-up duration is up to 5 years for each patient. As of October 2015, an interim analysis of 13,623 subjects was performed to understand the baseline clinical profiles of the study population. The mean age was 64.1 years; 73.5% were male; and 48.2% were diagnosed with ST-segment elevation AMI. Hypertension is a leading cause of AMI in Korea (51.2%), followed by smoking (38.5%) and diabetes mellitus (28.6%). Percutaneous coronary intervention was performed in 87.4% and its success rate was very high (99.4%). In-hospital, 1-year, and 2-year mortality rates were 3.9%, 4.3%, and 8.6%, respectively. The rates of major adverse cardiac events at 1 and 2 years were 9.6% and 18.8%, respectively.

Conclusions: This analysis demonstrated the clinical characteristics of Korean AMI patients in comparison with those of other countries. It is necessary to develop guidelines for Asian populations to further improve their prognosis. (Circ J 2016; 80: 1427-1436).

Citing Articles

Potent P2Y inhibitors in patients with acute myocardial infarction and cardiogenic shock.

Jo J, Lee S, Joh H, Kim H, Kim J, Hong Y Crit Care. 2025; 29(1):65.

PMID: 39915828 PMC: 11800629. DOI: 10.1186/s13054-025-05277-y.


The Western Denmark Heart Registry and Population-Based National Health Registries.

Gyldenkerne C, Olesen K, Thrane P, Hansen M, Stodkilde-Jorgensen N, Andersen M Clin Epidemiol. 2024; 16:825-836.

PMID: 39619160 PMC: 11608051. DOI: 10.2147/CLEP.S488498.


Optimal duration of medical therapy for patients with acute myocardial infarction.

Boo K, Joo S, Lee J, Choi J, Kim S, Ko G Medicine (Baltimore). 2024; 103(48):e40697.

PMID: 39612453 PMC: 11608708. DOI: 10.1097/MD.0000000000040697.


Comparison of Outcomes Between ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarctions Based on Left Ventricular Ejection Fraction.

Kim Y, Her A, Rha S, Choi C, Choi B, Park S J Clin Med. 2024; 13(22).

PMID: 39597888 PMC: 11595183. DOI: 10.3390/jcm13226744.


Risk of Bleeding and Ischemia in Elderly East Asian Patients with Diabetes Mellitus Treated with either Clopidogrel or Ticagrelor: From the Korean Acute Myocardial Infarction Registry-V.

Lee S, Jeong M, Oh S, Lim Y, Ahn J, Hyun D Chonnam Med J. 2024; 60(3):147-154.

PMID: 39381120 PMC: 11458316. DOI: 10.4068/cmj.2024.60.3.147.